
- /
- Supported exchanges
- / US
- / BIAF.NASDAQ
bioAffinity Technologies, Inc. (BIAF NASDAQ) stock market data APIs
bioAffinity Technologies, Inc. Financial Data Overview
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get bioAffinity Technologies, Inc. data using free add-ons & libraries
Get bioAffinity Technologies, Inc. Fundamental Data
bioAffinity Technologies, Inc. Fundamental data includes:
- Net Revenue: 8 809 K
- EBITDA: -9 024 766
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-20
- EPS/Forecast: -0.17
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
bioAffinity Technologies, Inc. News

The Zacks Analyst Blog Highlights Meta Platforms, ServiceNow, Booking, Vaso and bioAffinity Technologies
For Immediate Release Chicago, IL – July 1, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and ev...


VOR Skyrockets On Ex-China Rights To Autoimmune Drug, ADIL To Face FDA On Jul.29, PSTV Jumps 14%
(RTTNews) - What's driving the momentum in the following stocks? Vor Bio, Inc. (VOR) has secured ex-Greater China rights from RemeGen Co., Ltd. to develop and commercialize Telitacicept, a novel dual...

bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company focused on cancer diagnostics and targeted therapeutics, will present findings today related ...

bioAffinity Technologies receives Chinese patent for cancer therapy
SAN ANTONIO - bioAffinity Technologies, Inc. (NASDAQ:BIAF), currently trading at $0.23 and down nearly 88% over the past year, has been granted a patent by the China National Intellectual Property Adm...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.